NEW YORK (GenomeWeb News) – Swiss molecular diagnostics firm Diagnoplex today said that it has closed a Series A financing round, raising CHF 10 million ($8.3 million) in funding.
 
Diagnoplex said that it would use proceeds from the financing to further develop its Colox non-invasive test for early detection of colon cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.